But a gene panel analysis including the AGL gene by high-throughput sequencing (NGS) can lead to GSD III diagnosis in cases of isolated muscular symptomatology in adulthood (rare form) and when there are few indications or when they lack specificity [11–15]. The gene discussed is AGL; the disease is glycogen storage disease III.